Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangwei Granules for functional dyspepsia (postprandial distress syndrome)
ChiCTR2300077870Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Oct 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Yangwei Granules in functional dyspepsia (FD) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Response rate of improvement of postprandial fullness and early satiety at week 4. Started Oct 2023; status: recruiting.
02
Drugs
Yangwei Granules
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2300077870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077870.